The American Spectator

home
ADVERTISEMENT
Print Email
Text Size

The Spectacle Blog

The New York Times' "analysis" today of the Wal-Mart plan to sell some generic drugs for $4 per 30-day supply is (surprise!) not all it was initially cracked up to be:

Health care analysts were quick to point out that Wal-Mart has carefully chosen which drugs it will cover - 300 out of roughly 11,000 generic drugs available. Moreover, it is not offering some expensive drugs, like any of the cholesterol-lowering statins, at the $4 price. And some of the drugs covered, like generic ibuprofen, cost very little and may be currently available for less than $4. "They are not losing money on all these products," said Patricia Wilson, a health care consultant.

Yeah, it's really not a good deal because unrelentingly capitalistic Wal-Mart is only offering some of the drugs at a great deal and is not willing to take a bath on much more expensive pharmaceuticals. Liberals aren't happy until businesses lose money in the process of giving their workers unlimited benefits. Wait, that's not true, because I don't know of anybody who's too happy about Ford and GM right now...

topics:
Health Care, Business

Leave a comment

Leave a Comment

N.B. We encourage readers to share and discuss their thoughtful and relevant comments about this Spectator article. Comments are routinely monitored and will be deleted if profane, bigoted, or grossly impolite. Please be respectful. (And don't feed the trolls!) Thank you.

Related Blog Posts

More Blog Posts by Paul Chesser

http://spectator.org/blog/2006/09/22/re-oppressively-low-prices-fro

ADVERTISEMENT

SPONSORED LINKS

Special Feature

Better that we become a nation of choosers rather than beggars. Our symposium on choice from the May, 2012 issue:

A Time for Choosing

James Piereson

The Road from Serfdom

Stephen Moore and Peter Ferrara

FLASHBACK TO: 1984

Clip of the Day

Most Popular Articles

Meet the Flukes!

F. H. Buckley | 5.25.12

The Wisconsin Turning Point

Peter Ferrara | 5.23.12

In Search of Muhammad

Aymenn Jawad Al-Tamimi | 5.25.12

Age and Kyl

Quin Hillyer | 5.25.12

Follow Me

Jay D. Homnick | 5.25.12

A Test of National Honor

Hal G.P. Colebatch | 5.25.12

How About the Record of DOE Capital?

William Tucker | 5.25.12

The Great Debate

R. Emmett Tyrrell, Jr. | 5.24.12

ADVERTISEMENT